BIOMAT Database Logo BIOMAT Database Logo

[The assessment of preoperative transcatheter arterial embolization (TAE) for hepatocellular carcinoma (HCC)--the comparison between "whole-liver" TAE and "lobar or segmental" TAE]. 1991

S Masutani, and Y Sasaki, and S Imaoka, and I Ohashi, and O Ishikawa, and H Furukawa, and I Fukuda, and T Kabuto, and M Fujita, and H Koyama
Department of Surgery, Center for Adult diseases, Osaka.

In 180 patients with hepatocellular carcinoma (HCC) who underwent radical hepatectomy, 52 patients were received preoperative arterial chemoembolization (TAE) for the whole liver (whole-liver TAE group: group A), 39 for the limited area of the liver (lobar or segmental TAE group: group B) and the remaining 89 had no treatments before surgery (control group: group C). In order to evaluate the significance of preoperative TAE, long-term prognoses were compared among the three groups. Although there were no significant differences in survivals between A and C, the 2- and 6-year survivals in group B were significantly better than those in group C (P less than 0.05). With regard to reduction rates of tumors and necrotizing effect for daughter nodules after TAE, the lobar or segmental TAE was significantly superior to the whole-liver TAE. Moreover, the lobar or segmental TAE deteriorated the liver function significantly less than the whole-liver TAE. These findings suggest that the lobar or segmental TAE is more advantageous than the whole-liver TAE as a preoperative adjuvant therapy.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011300 Preoperative Care Care given during the period prior to undergoing surgery when psychological and physical preparations are made according to the special needs of the individual patient. This period spans the time between admission to the hospital to the time the surgery begins. (From Dictionary of Health Services Management, 2d ed) Care, Preoperative,Preoperative Procedure,Preoperative Procedures,Procedure, Preoperative,Procedures, Preoperative
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004621 Embolization, Therapeutic A method of hemostasis utilizing various agents such as Gelfoam, silastic, metal, glass, or plastic pellets, autologous clot, fat, and muscle as emboli. It has been used in the treatment of spinal cord and INTRACRANIAL ARTERIOVENOUS MALFORMATIONS, renal arteriovenous fistulas, gastrointestinal bleeding, epistaxis, hypersplenism, certain highly vascular tumors, traumatic rupture of blood vessels, and control of operative hemorrhage. Embolotherapy,Therapeutic Embolization,Embolizations, Therapeutic,Embolotherapies,Therapeutic Embolizations
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006498 Hepatectomy Excision of all or part of the liver. (Dorland, 28th ed) Hepatectomies

Related Publications

S Masutani, and Y Sasaki, and S Imaoka, and I Ohashi, and O Ishikawa, and H Furukawa, and I Fukuda, and T Kabuto, and M Fujita, and H Koyama
[A combination treatment of transcatheter arterial embolization (TAE) and irradiation for hepatocellular carcinoma (HCC)--evaluation for therapeutic efficacy in comparison with TAE or irradiation alone].
February 1990, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
S Masutani, and Y Sasaki, and S Imaoka, and I Ohashi, and O Ishikawa, and H Furukawa, and I Fukuda, and T Kabuto, and M Fujita, and H Koyama
Acute pancreatitis after transcatheter arterial embolization (TAE) for hepatocellular carcinoma.
November 1989, The American journal of gastroenterology,
S Masutani, and Y Sasaki, and S Imaoka, and I Ohashi, and O Ishikawa, and H Furukawa, and I Fukuda, and T Kabuto, and M Fujita, and H Koyama
Segmental transcatheter arterial embolization for primary hepatocellular carcinoma.
December 1998, World journal of gastroenterology,
S Masutani, and Y Sasaki, and S Imaoka, and I Ohashi, and O Ishikawa, and H Furukawa, and I Fukuda, and T Kabuto, and M Fujita, and H Koyama
[Therapeutic value of hepatectomy and transcatheter arterial embolization (TAE) for hepatocellular carcinoma].
September 1992, Nihon Geka Gakkai zasshi,
S Masutani, and Y Sasaki, and S Imaoka, and I Ohashi, and O Ishikawa, and H Furukawa, and I Fukuda, and T Kabuto, and M Fujita, and H Koyama
Survival outcome of lobar or segmental transcatheter arterial embolization with ethanol-lipiodol mixture in treating hepatocellular carcinoma.
May 2005, World journal of gastroenterology,
S Masutani, and Y Sasaki, and S Imaoka, and I Ohashi, and O Ishikawa, and H Furukawa, and I Fukuda, and T Kabuto, and M Fujita, and H Koyama
[Successful experience in transcatheter arterial embolization (TAE) after visualizing extravasation due to rupture of hepatocellular carcinoma (HCC)].
June 1988, Rinsho hoshasen. Clinical radiography,
S Masutani, and Y Sasaki, and S Imaoka, and I Ohashi, and O Ishikawa, and H Furukawa, and I Fukuda, and T Kabuto, and M Fujita, and H Koyama
[Hepatectomy after transcatheter arterial embolization (TAE) for hepatocellular carcinomas].
May 1985, Nihon Geka Gakkai zasshi,
S Masutani, and Y Sasaki, and S Imaoka, and I Ohashi, and O Ishikawa, and H Furukawa, and I Fukuda, and T Kabuto, and M Fujita, and H Koyama
[Evaluation of preoperative transcatheter arterial embolization for hepatocellular carcinoma].
October 1982, Nihon Gan Chiryo Gakkai shi,
S Masutani, and Y Sasaki, and S Imaoka, and I Ohashi, and O Ishikawa, and H Furukawa, and I Fukuda, and T Kabuto, and M Fujita, and H Koyama
[Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma].
February 1998, Gan to kagaku ryoho. Cancer & chemotherapy,
S Masutani, and Y Sasaki, and S Imaoka, and I Ohashi, and O Ishikawa, and H Furukawa, and I Fukuda, and T Kabuto, and M Fujita, and H Koyama
[Hepatic arterial infusion chemotherapy (HAI) for advanced hepatocellular carcinoma inefficacious with transcatheter arterial embolization (TAE)].
May 1998, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!